Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
80.01
-2.14 (-2.60%)
Mar 9, 2026, 3:00 PM CST

SHA:688266 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
21,17924,53816,49414,01410,00814,112
Upgrade
Market Cap Growth
24.63%48.77%17.70%40.02%-29.08%-9.11%
Upgrade
Enterprise Value
20,21923,57815,21312,6589,44313,028
Upgrade
Last Close Price
80.0192.7062.3152.9441.7058.80
Upgrade
Forward PE
90.7535.5135.5135.5135.51-
Upgrade
PS Ratio
26.0630.1930.9536.2633.1174.13
Upgrade
PB Ratio
18.4321.3613.178.5212.7111.26
Upgrade
P/TBV Ratio
19.0222.0413.708.9614.9813.07
Upgrade
P/OCF Ratio
--431.73---
Upgrade
EV/Sales Ratio
24.8829.0128.5432.7631.2468.44
Upgrade
Debt / Equity Ratio
0.980.980.830.540.700.18
Upgrade
Net Debt / Equity Ratio
-0.84-0.84-0.92-0.83-0.63-0.78
Upgrade
Net Debt / EBITDA Ratio
7.827.826.633.821.032.11
Upgrade
Net Debt / FCF Ratio
--20.094.601.091.86
Upgrade
Asset Turnover
--0.180.170.180.10
Upgrade
Inventory Turnover
--0.260.300.370.19
Upgrade
Quick Ratio
--1.712.081.573.35
Upgrade
Current Ratio
--1.882.221.773.69
Upgrade
Return on Equity (ROE)
-13.38%-13.38%-10.37%-24.27%-47.59%-31.38%
Upgrade
Return on Assets (ROA)
---4.60%-10.91%-19.70%-17.02%
Upgrade
Return on Capital Employed (ROCE)
---13.30%-22.70%-57.30%-37.10%
Upgrade
Earnings Yield
-0.76%-0.66%-0.84%-1.99%-4.57%-3.20%
Upgrade
FCF Yield
---0.35%-2.11%-4.59%-3.72%
Upgrade
Buyback Yield / Dilution
0.61%0.61%-3.71%-6.74%0.19%-2.20%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.